Analyst Reco. Cross Country Healthcare, Inc.

Equities

CCRN

US2274831047

Market Closed - Nasdaq Other stock markets 21:00:00 30/04/2024 BST			5-day change	1st Jan Change
17.6 ^USD	+0.28%		-0.96%	-22.26%

04-25	Cross Country Healthcare, Inc. Releases Latest Research Findings in the Fourth Annual Installment of the Future of Nursing Survey	CI
02-27	Barrington Cuts Price Target on Cross Country Healthcare to $24 From $26, Keeps Outperform Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barrington Cuts Price Target on Cross Country Healthcare to $24 From $26, Keeps Outperform Rating	02-27	MT
UBS Adjusts Cross Country Healthcare Price Target to $19 From $22, Maintains Neutral Rating	02-23	MT
Truist Adjusts Cross Country Healthcare's Price Target to $16 From $22, Keeps Hold Rating	02-22	MT
JMP Securities Initiates Cross Country Healthcare With Market Perform Rating	12-06	MT
UBS Initiates Coverage on Cross Country Healthcare With Neutral Rating, $22 Price Target	11-30	MT
Barrington Cuts Price Target on Cross Country Healthcare to $26 From $29, Keeps Outperform Rating	11-29	MT
Jefferies Downgrades Cross Country Healthcare to Hold From Buy, Adjusts Price Target to $21 From $32	11-03	MT
Barrington Cuts Price Target on Cross Country Healthcare to $29 From $35 Amid Reduction in Estimates, Keeps at Outperform	14/08/23	MT
Credit Suisse Adjusts Cross Country Healthcare's Price Target to $26 From $27, Keeps Neutral Rating	08/08/23	MT
William Blair Initiates Cross Country Healthcare at Outperform Rating	26/06/23	MT
Barrington Research Cuts Cross Country Healthcare's Price Target to $35 From $42, Maintains Outperform Rating	31/05/23	MT
Credit Suisse Lowers Cross Country Healthcare's Price Target to $27 From $32, Keeps Neutral Rating	05/05/23	MT
Truist Securities Adjusts Cross Country Healthcare Price Target to $25 From $38, Maintains Hold Rating	02/05/23	MT
Loop Capital Initiates Cross Country Healthcare at Buy Rating With $30 Price Target	10/03/23	MT
Barrington Trims Price Target on Cross Country Healthcare to $42 From $45, Reiterates Outperform Rating	01/03/23	MT
Benchmark Capital Adjusts Cross Country Healthcare Price Target to $40 From $45, Maintains Buy Rating	23/02/23	MT
Credit Suisse Lifts Cross Country Healthcare's Price Target to $32 From $31 After Higher-Than-Expected Q4 Results, Keeps Neutral Rating	23/02/23	MT
Barrington Raises Price Target on Cross Country Healthcare to $45 From $41, Affirms Outperform Rating	07/11/22	MT
Truist Securities Downgrades Cross Country Healthcare to Hold From Buy; Price Target is $36	05/10/22	MT
Barrington Research Raises Price Target for Cross Country Healthcare to $41 From $40, Maintains Outperform Rating	15/09/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Cross Country Healthcare, Inc.

Equities

CCRN

US2274831047

Analyst Reco.

Filters